Skip to content

Editorial & Review Policy

This page documents who writes the content on the Migibio Data Hub, how it is reviewed, what evidence standards it must meet, and how to report an error. This site hosts structured reference data — biomarker values, reference ranges, and performance metrics — so every numeric value must trace to a citable validation source.

1. Authorship

Content is produced by the Migibio Clinical & Scientific Affairs team — immunoassay development engineers, regulatory-affairs specialists, and application scientists who work directly on the FICT platform and its validation. Content is attributed at the organization level; we do not fabricate individual author names.

2. Review

Every page is reviewed by the Migibio R&D Quality Committee before publication, checking technical accuracy, clinical correctness against current veterinary guidelines (e.g., IRIS CKD staging, ACVIM consensus), regulatory compliance, and source integrity.

3. Citation & Evidence Standards

  • Quantitative claims (reference ranges, LOD, CV%, sensitivity/specificity) must trace to an internal Migibio validation report or a recognized external source.
  • Clinical interpretation references recognized veterinary guidelines where they exist.
  • Migibio-specific figures are labeled as such — never presented as industry-universal values.

4. Conflict of Interest

Migibio (Guangzhou Magic Biotech Co., Ltd.) is the manufacturer of the FIA680/FIA880 analyzers and FICT reagents described on this site. This is a manufacturer-published technical resource, and that relationship is disclosed on every page and in our structured data.

5. Correction Policy

To report an error, email martinwang2024@gmail.com with the page URL and the specific issue. Material corrections affecting clinical interpretation are prioritized.

6. Scope

This site is a technical reference for trained veterinary professionals. It is not a substitute for the official Instructions for Use (IFU), which is the legally controlling document.

Last reviewed: 2026-08-13 by the Migibio R&D Quality Committee.

Authored by: Migibio Clinical & Scientific Affairs, Guangzhou Magic Biotech Co., Ltd.

Reviewed by: Migibio R&D Quality Committee

Last updated: 2026-08-13

Disclosure: Migibio (Guangzhou Magic Biotech Co., Ltd.) is the manufacturer of the FIA680/FIA880 analyzers and FICT reagents referenced in this content. See our Editorial & Review Policy.

Contact: Martin.Wong  ·  Phone (WhatsApp): +86 13323237275  ·  Email: martinwang2024@gmail.com
Back to top